LeMaitre Vascular, Inc.
LMATNASDAQHealthcare● Active
$94.80
+$0.32(+0.33%)
Market Cap$2.2B
P/E Ratio—
52W High$118.01
52W Low$79.01
LeMaitre Vascular, Inc. (LMAT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LMAT · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.25B | $0.22B | $0.19B | $0.16B | $0.15B |
| Cost of Revenue | $0.07B | $0.07B | $0.07B | $0.06B | $0.05B |
| Gross Profit | $0.18B | $0.15B | $0.13B | $0.10B | $0.10B |
| Gross Margin %(computed) | 71.53% | 68.63% | 65.66% | 64.89% | 65.65% |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.02B | $0.02B | $0.01B | $0.01B |
| G&A Expenses | $0.04B | $0.04B | $0.03B | $0.03B | $0.03B |
| Total Operating Expenses | $0.11B | $0.10B | $0.09B | $0.08B | $0.06B |
| Operating Income | $0.07B | $0.05B | $0.04B | $0.03B | $0.04B |
| Operating Margin %(computed) | 27.21% | 23.77% | 18.97% | 16.60% | 23.59% |
| Interest Income | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.08B | $0.06B | $0.04B | $0.03B | $0.03B |
| Income Tax Expense | $0.02B | $0.01B | $0.01B | $0.01B | $0.01B |
| Net Income | $0.06B | $0.04B | $0.03B | $0.02B | $0.03B |
| Net Margin %(computed) | 23.13% | 20.03% | 15.56% | 12.77% | 17.42% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $2.55 | $1.96 | $1.36 | $0.94 | $1.27 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| EBITDA | $0.09B | $0.07B | $0.05B | $0.04B | $0.05B |
| EBITDA Margin %(computed) | 36.37% | 30.36% | 25.32% | 22.84% | 29.78% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more LeMaitre Vascular, Inc. data
About LeMaitre Vascular, Inc. (LMAT) Income Statement
LeMaitre Vascular, Inc. (LMAT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, LMAT reported revenue of $0.25B, gross profit of $0.18B (gross margin 71.53%), and net income of $0.06B — a net profit margin of 23.13%.
Frequently asked questions
LMAT · 4 questionsLeMaitre Vascular, Inc. (LMAT) reported revenue of $0.25B for 2025, up 13.5% year-over-year.
LMAT revenueLMAT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08